Health-related quality of life (HRQOL) and patient-centered outcomes with maintenance olaparib compared with placebo following chemotherapy in patients with germline BRCA-mutated platinum-sensitive relapsed serous ovarian cancer: SOLO2 Phase III
ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 88-89
Erscheinungsjahr: 2018
Publikationstyp: Zeitschriftenaufsatz
| Geprüft | Bibliothek |
Autoren
Hasenburg, A. (Autor)
Harter, P. (Autor)
Park-Simon, T-W. (Autor)
Gropp-Meier, M. (Autor)
Heitz, F. (Autor)
Soergel, P. (Autor)
Ataseven, B. (Autor)
Friedlaender, M. (Autor)
Hilpert, F. (Autor)
Pujade-Lauraine, E. (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
